(Q67841935)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1783521%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Differences in N-acetylation of the experimental antitumor agent batracylin in the mouse and the rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1783521%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

author name string

M M Ames

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1783521%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

D A Mathiesen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1783521%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

J M Reid

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1783521%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1783521%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

18 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1783521%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1783521%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1783521%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

219-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1783521%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00176974

18 September 2019

exact match

0 references

cites work

Potential roles for preclinical pharmacology in phase I clinical trials

1 reference

12 December 2020

Preclinical antitumor activity of batracylin (NSC 320846).

1 reference

12 December 2020

Metabolic activation and drug toxicity

1 reference

12 December 2020

N-acetylation pharmacogenetics

1 reference

12 December 2020

High-performance liquid chromatographic assay and preclinical pharmacologic studies with the experimental antitumor agent batracylin

1 reference

12 December 2020